Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SōRSE Technology has developed and commercialized a proprietary water-soluble emulsion platform that enables the integration of cannabinoids and other oil-based functional ingredients into beverages, foods, topicals, and medical products. The company's technology is being used in over 45 market-leading CBD/hemp products globally. In partnership with Pascal Biosciences, the first clinical trial using this formulation for oral cannabinoid delivery in cancer patients treated with checkpoint inhibitors was initiated as of late 2020[2][3][4]. No direct clinical results have been published by SōRSE itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SōRSE Technology.